JWH-424
JWH-424[edit]

JWH-424 is a synthetic cannabinoid that acts as a potent agonist at the cannabinoid receptors. It is part of the naphthoylindole family of compounds, which are known for their ability to mimic the effects of tetrahydrocannabinol (THC), the primary psychoactive component of cannabis.
Chemical Properties[edit]
JWH-424 is characterized by its complex chemical structure, which includes a naphthoylindole core. The chemical formula for JWH-424 is C24H23NO, and it has a molecular weight of 341.45 g/mol. The structure of JWH-424 allows it to bind effectively to cannabinoid receptors, particularly the CB1 receptor and CB2 receptor.
Pharmacology[edit]
JWH-424 functions as a full agonist at both CB1 and CB2 receptors, which are part of the endocannabinoid system. This system plays a crucial role in regulating various physiological processes, including pain, appetite, mood, and memory. The activation of these receptors by JWH-424 can lead to effects similar to those produced by natural cannabinoids, such as analgesia, euphoria, and sedation.
Legal Status[edit]
Due to its psychoactive properties, JWH-424, like many other synthetic cannabinoids, has been subject to legal restrictions in various countries. These compounds are often included in the list of controlled substances due to their potential for abuse and lack of medical use.
Synthesis[edit]
The synthesis of JWH-424 involves the reaction of a naphthoyl chloride with an indole derivative. This process is similar to the synthesis of other naphthoylindole compounds. The specific conditions and reagents used can vary, but the general approach involves forming the naphthoylindole core through a condensation reaction.
Potential Risks and Side Effects[edit]
The use of JWH-424, like other synthetic cannabinoids, can pose significant health risks. These may include tachycardia, hypertension, anxiety, hallucinations, and psychosis. The variability in potency and purity of synthetic cannabinoids can also lead to unpredictable effects and increased risk of overdose.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian